Korsana Biosciences, Inc. (KRSA) — Institutional Holders, Q2 2026

21 institutional investment managers reported a KRSA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $11.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

KRSA 13F holders ranked 1–21 of 21

Institutional investors reporting a position in Korsana Biosciences, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Kalehua Capital Management#1 · 1,651,350 sh$5.6MNew
FMR#2 · 649,547 sh$2.2MNew
BALYASNY ASSET MANAGEMENT L.P.#3 · 317,511 sh$1.1MNew
ADAR1 Capital Management#4 · 298,757 sh$1.0MNew
BRAIDWELL#5 · 156,890 sh$531.9KNew
CITADEL ADVISORS#6 · 59,795 sh$202.7K+227.4%
GEODE CAPITAL MANAGEMENT#7 · 45,850 sh$155.5K-45.8%
VANGUARD CAPITAL MANAGEMENT#8 · 30,915 sh$104.8K+91.6%
Rangeley Capital#9 · 24,310 sh$82.4KNew
HRT FINANCIAL#10 · 22,054 sh$74.0KNew
BlackRock#11 · 16,797 sh$56.9K0.0%
DIMENSIONAL FUND ADVISORS#12 · 11,724 sh$39.7KNew
VANGUARD FIDUCIARY#13 · 7,353 sh$24.9K0.0%
UBS Group AG#14 · 3,135 sh$10.6K-7.5%
Tower Research Capital (TRC)#15 · 1,849 sh$6.3KNew
GROUP ONE TRADING, L.P.#16 · 192 sh$651.000.0%
OSAIC#17 · 130 sh$440.000.0%
Activest Wealth Management#18 · 100 sh$339.000.0%
BARCLAYS PLC#19 · 87 sh$295.00New
WHI#20 · 72 sh$244.000.0%
BNP PARIBAS FINANCIAL MARKETS#21 · 4 sh$14.00-20.0%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.